Media

Press Releases

Hogan Lovells advises Medicines Development for Global Health in the Sale of its Priority Review Voucher

New York, 14 May 2019 – A team from Hogan Lovells has advised Medicines Development for Global Health (MDGH) in the sale of its Priority Review Voucher (PRV).

Press Releases

Hogan Lovells advises Gilead Sciences on its collaboration with Goldfinch Bio to develop novel therapies for kidney disease

New York, 8 May 2019 – A team from Hogan Lovells has advised Gilead Sciences on a partnership with Goldfinch Bio, a biotechnology company focused on developing precision therapies for ...

Press Releases

Hogan Lovells advises PerkinElmer, Inc. on its acquisition of Cisbio Bioassays

Hogan Lovells advised PerkinElmer, Inc. on its acquisition of Cisbio Bioassays.

Press Releases

Hogan Lovells Represents LabCorp in Net US$485 Million Complex Strategic Acquisition and Divestiture

New York, Washington D.C., 17 April 2019 – Hogan Lovells is representing LabCorp, a leading global life sciences company, in a complex two-way acquisition and divestiture transaction...

Awards and Rankings

Hogan Lovells Paris has improved its rankings in five categories in The Legal 500 EMEA France 2019

Hogan Lovells is delighted to announce the progress by its teams in five categories of The Legal 500 EMEA France.

Media Mention

Biotech companies see opportunities in new listing rules

Stephen Peepels was quoted by GlobalCapital Asia as saying a number of biotech companies explored potential IPOs following changes in Hong Kong’s listing rules.

Press Releases

Hogan Lovells advises Osiris in US$660 million acquisition by Smith & Nephew

Washington, D.C., 13 March 2019 – International law firm Hogan Lovells has advised Osiris Therapeutics, Inc., (NASDAQ: OSIR), a developer of regenerative medicine products, in an...

Press Releases

Hogan Lovells examines innovation and challenges in the life sciences and health care industries with second annual report

Washington, D.C.,12 March 2019 – Global law firm Hogan Lovells today published Life Sciences and Health Care Horizons, the firm’s second annual insight into current and...

Loading data